22 Healthcare Stocks Moving In Thursday's Pre-Market Session

Loading...
Loading...

Gainers

  • Tocagen, Inc. TOCA stock surged 60.7% to $0.78 during Thursday's pre-market session.
  • Brickell Biotech, Inc. BBI stock increased by 51.1% to $2.75.
  • Community Health Systems, Inc. CYH stock increased by 14.5% to $5.50. According to the most recent rating by Raymond James, on February 20, the current rating is at Market Perform.
  • Salarius Pharmaceuticals, Inc. SLRX shares surged 10.6% to $1.06.
  • Tonix Pharmaceuticals, Inc. TNXP shares increased by 7.1% to $0.45.
  • Smith & Nephew, Inc. SNN stock increased by 7.0% to $51.60.
  • Ritter Pharmaceuticals, Inc. RTTR shares surged 6.8% to $0.20.
  • TherapeuticsMD, Inc. TXMD stock increased by 5.4% to $2.53.
  • Cyclerion Therapeutics, Inc. CYCN shares surged 4.3% to $6.09.
  • Rigel Pharmaceuticals, Inc. RIGL stock increased by 3.9% to $2.40. The most recent rating by BMO Capital, on December 09, is at Outperform, with a price target of $8.00.
  • Aurora Cannabis, Inc. ACB shares increased by 3.2% to $1.76. The most recent rating by Piper Sandler, on January 10, is at Underweight, with a price target of $1.00.
  • Fresenius Medical Care, Inc. FMS stock rose 2.4% to $41.87. According to the most recent rating by Jefferies, on January 21, the current rating is at Buy.
  • Twist Bioscience, Inc. TWST stock moved upwards by 2.1% to $29.05.

 

Losers

  • Tivity Health, Inc. TVTY shares declined 37.2% to $14.39 during Thursday's pre-market session. According to the most recent rating by SunTrust Robinson Humphrey, on February 20, the current rating is at Hold.
  • AEterna Zentaris, Inc. AEZS stock plummeted 26.5% to $1.00.
  • BioXcel Therapeutics, Inc. BTAI shares decreased by 18.6% to $33.50. The most recent rating by SunTrust Robinson Humphrey, on February 14, is at Buy, with a price target of $150.00.
  • Viveve Medical, Inc. VIVE shares declined 13.9% to $1.55. According to the most recent rating by Ladenburg Thalmann, on December 03, the current rating is at Buy.
  • Invitae, Inc. NVTA shares decreased by 8.7% to $25.15.
  • Axovant Gene Therapies, Inc. AXGT shares plummeted 8.4% to $4.01.
  • Heron Therapeutics, Inc. HRTX stock fell 5.9% to $20.38. The most recent rating by Needham, on February 20, is at Buy, with a price target of $48.00.
  • AVEO Pharmaceuticals, Inc. AVEO stock decreased by 5.3% to $4.99.
  • Teva Pharmaceutical Indus, Inc. TEVA shares decreased by 2.4% to $13.14. The most recent rating by Argus Research, on February 18, is at Buy, with a price target of $15.00.
Loading...
Loading...
Posted In: Pre-Market OutlookMarketsMoversTrading IdeasHealthcare Stocks Pre-Market MoversTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...